Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Needham analyst Gil Blum initiated coverage on Kazia Therapeutics Limited (NASDAQ:KZIA) with a Buy rating and announced a price target of $27. Kazia Therapeutics closed at $8.72 on Thursday. See how other analysts view this stock.
• Cantor Fitzgerald analyst Troy Jensen initiated coverage on Pasqal Holding SA (NASDAQ:PSQL) with an Overweight rating and announced a price target of $12. Pasqal Holding shares closed at $5.24 on Thursday. See how other analysts view this stock.
• Maxim Group analyst Naz Rahman initiated coverage on Nasus Pharma Ltd. (AMEX:NSRX) with a Buy rating and announced a price target of $7. Nasus Pharma closed at $3.19 on Thursday. See how other analysts view this stock.
• Maxim Group analyst Anthony Vendetti initiated coverage on Legacy Education Inc. (AMEX:LGCY) with a Buy rating and announced a price target of $16. Legacy Education shares closed at $10.22 on Thursday. See how other analysts view this stock.

Considering buying KZIA stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.